RENAL MEDULLA AND BRADYKININ DURING THE DEVELOPMENT OF HYPERTENSION IN SHR

Citation
Jb. Osullivan et al., RENAL MEDULLA AND BRADYKININ DURING THE DEVELOPMENT OF HYPERTENSION IN SHR, Clinical and experimental pharmacology and physiology, 22(6-7), 1995, pp. 463-465
Citations number
12
Categorie Soggetti
Pharmacology & Pharmacy",Physiology
ISSN journal
03051870
Volume
22
Issue
6-7
Year of publication
1995
Pages
463 - 465
Database
ISI
SICI code
0305-1870(1995)22:6-7<463:RMABDT>2.0.ZU;2-B
Abstract
1. The long-term reduction in blood pressure following ACE inhibitor t reatment in young spontaneously hypertensive rats (SHR) appears to dep end on both the kidney and bradykinin. 2. The aim of this experiment w as to examine the effects of ACE inhibition and bradykinin on renal mo rphology and blood pressure in SHR. 3. Between 6 and 10 weeks of age m ale SHR received one of four treatments: water (n = 26), ramipril (1 m g/kg per day; n = 24), ramipril (1 mg/kg per day) plus Hoe 140 (0.5 mg /kg per day; n = 25) or Hoe140 (0.5 mg/kg per day; n = 25). 4. Renal m edullary and cortical volumes were determined stereologically at 10 an d 20 weeks of age. 5. After 4 weeks of treatment, ramipril reduced the size of the renal medulla while Hoe 140 increased medullary volumes c ompared to control. Ten weeks after treatment was stopped the renal me dulla of the ramipril group had returned to normal, however, there was a persistent increase in medullary volume of both Hoe 140 treated gro ups. 6. Our results imply that bradykinin may influence the size of th e renal medulla which may have important effects on the development of hypertension in SHR.